Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor

  1. Debanjan Bhattacharjee
  2. Jaweria Bakar
  3. Surbhi P. Chitnis
  4. Erin L. Sausville
  5. Kumar Dilip Ashtekar
  6. Brianna E. Mendelson
  7. Kaitlin Long
  8. Joan C. Smith
  9. David E. Heppner
  10. Jason M. Sheltzer
Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.chembiol.2023.09.013
  2. Version published to 10.1101/2022.10.16.512438 on bioRxiv